Kamal S. Saini

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

Kamal S. Saini, Sherene Loi, Evandro de Azambuja et al. · Cancer Treatment Reviews · 2013 · 378 citations

Medicine, Oncology, Pharmacology +14

DNA methylation profiling reveals a predominant immune component in breast cancers

Sarah Dedeurwaerder, Christine Desmedt, Emilie Calonne et al. · EMBO Molecular Medicine · 2011 · 232 citations · Full text

Medicine, Immunology, Oncology +17

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Kamal S. Saini, Catherine Taylor, Antonio J. Ramírez et al. · Annals of Oncology · 2011 · 212 citations · Full text

Medicine, Oncology, Breast Oncology +13

Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain

Carsten K. Nielsen, F. B. Ross, Shahrdad Lotfipour et al. · Pain · 2007 · 184 citations

Medicine, Neuroscience, Pharmacology +17

Effect of the COVID-19 pandemic on cancer treatment and research

Kamal S. Saini, Begoña de las Heras, Ramachandran Venkitaraman et al. · The Lancet Haematology · 2020 · 161 citations · Full text

Public Affairs, Health Care Management, Health Policy +16